Bridgeway Capital Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Bridgeway Capital Management’s Portfolio SKBI Stock Details SKBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-24,300	Closed	-$65K	–	1583
2015 Q2	$65K	Hold	24,300	–	–	﹤0.01%	1454
2015 Q1	$95K	Hold	24,300	–	–	﹤0.01%	1418
2014 Q4	$103K	Hold	24,300	–	–	﹤0.01%	1388
2014 Q3	$102K	Hold	24,300	–	–	﹤0.01%	1423
2014 Q2	$178K	Hold	24,300	–	–	﹤0.01%	1346
2014 Q1	$159K	Buy	+24,300	New	+$123K	﹤0.01%	1354

Other funds holding SKBI

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgeway Capital Management's SKBI Position: Q3 2015 in Review

Bridgeway Capital Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 24,300 shares — an estimated $65K sold.

Bridgeway Capital Management first reported a position in SKBI in Q1 2014 and held it in 6 quarters. The position peaked at $178K in Q2 2014. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

Bridgeway Capital Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
Bridgeway Capital Management sold 24,300 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015, an estimated $65K.
Bridgeway Capital Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q1 2014 and held it in 6 quarters.
Bridgeway Capital Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $178K in Q2 2014.
10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on Bridgeway Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.